{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:45:45Z","timestamp":1793400345668,"version":"4.5.0"},"reference-count":130,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pemphigus is an autoimmune blistering disorder characterized by the presence of intraepidermal blisters and erosions, primarily affecting the mucosa and\/or skin. There are no established Indian guidelines for the management of pemphigus, and Western guidelines cannot be directly applied due to differences in clinicodemographic profiles, comorbidities, and resource limitations. These guidelines aim to provide Indian dermatologists with evidence-based and consensus-driven recommendations for the management of pemphigus vulgaris (PV) and pemphigus foliaceous (PF), taking into account the unique challenges posed by the Indian healthcare setting. The guidelines focus on the comprehensive management of PV and PF, addressing diagnosis, treatment, monitoring, and follow-up. It is intended for dermatologists working in both outpatient and inpatient settings across India. The first draft of the guidelines was prepared by the writing group and then reviewed by 19 national experts in pemphigus management, including inputs from allied specialties. Areas with limited evidence or anticipated variation in recommendations were subjected to rounds of voting, with responses categorized as \u201cstrongly agree,\u201d \u201cagree,\u201d \u201cneutral,\u201d \u201cdisagree,\u201d or \u201cstrongly disagree.\u201d Suggestions were incorporated, and statements were revised until a mean agreement score of 4 or higher was reached across 16 key areas after four voting rounds. These guidelines offer a structured approach to managing pemphigus in India, addressing the need for region-specific recommendations that account for unique challenges such as resource constraints and specific comorbidities in Indian patients. They serve as a valuable resource for dermatologists treating pemphigus in a range of clinical settings.<\/jats:p>","DOI":"10.4103\/idoj.idoj_1059_24","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T14:00:22Z","timestamp":1735221622000},"page":"3-24","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous"],"prefix":"10.4103","volume":"16","author":[{"given":"Dipankar","family":"De","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitaishi","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidangazhiathmana","family":"Ajithkumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Govenment Medical College, Kottayam, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamanta","family":"Barua","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Assam Medical College and Hospital, Dibrugarh, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmisha","family":"Chandrashekar","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Armed Forces Medical Services and Consultant Dermatologist, Base Hospital, Delhi Cantt, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Khandpur","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeti","family":"Khullar","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, Lady Hardinge Medical College, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetharam Anjaneyulu","family":"Kolalapudi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, GSL Medical College, Rajahmundry, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetanshu","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Neema","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Pandhi","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, University College of Medical Sciences and GTBH, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shital","family":"Poojary","sequence":"additional","affiliation":[{"name":"Department of Dermatology, K. J. Somaiya Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murlidhar","family":"Rajagopalan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, and Leprology at Apollo Hospitals, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kasturba Medical College, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Dermatology, B. J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singal","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, University College of Medical Sciences and GTBH, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Aggrawal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"De","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Prinja","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"R1-20241226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0378-6323.13781","article-title":"A study of mortality in dermatology","volume":"71","author":"Nair","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R2-20241226","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0378-6323.82396","article-title":"Pemphigus in India","volume":"77","author":"Kanwar","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R3-20241226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.2005.06882.x","article-title":"Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris","volume":"154","author":"Capon","year":"2006","journal-title":"Br J Dermatol"},{"key":"R4-20241226","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaad.2008.07.059","article-title":"The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesions","volume":"59","author":"Durdu","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R5-20241226","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/2229-5178.169729","article-title":"Diagnostic value of Tzanck smear in various erosive, vesicular, and bullous skin lesions","volume":"6","author":"Yaeen","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"R6-20241226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.25259\/JSSTD_13_2019","article-title":"Sensitivity, specificity, and positive predictive value of Tzanck smear in diagnosing intraepidermal immunobullous diseases in patients presenting with immunobullous diseases","volume":"1","author":"Chandrasekhar","year":"2019","journal-title":"J Skin Sexually Transmitted Dis"},{"key":"R7-20241226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjd.14408","article-title":"Laboratory diagnosis of pemphigus:Direct immunofluorescence remains the gold standard","volume":"175","author":"Giurdanella","year":"2016","journal-title":"Br J Dermatol"},{"key":"R8-20241226","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0019-5154.135488","article-title":"A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses","volume":"59","author":"Buch","year":"2014","journal-title":"Indian J Dermatol"},{"key":"R9-20241226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/idoj.IDOJ_280_16","article-title":"Comparison of direct immunofluorescence of plucked hair and skin for evaluation of immunological remission in pemphigus","volume":"8","author":"Rai","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"R10-20241226","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17405","article-title":"Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris","author":"Malhi","year":"2024","journal-title":"Int J Dermatol"},{"key":"R11-20241226","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.jaad.2010.09.721","article-title":"Direct immunofluorescence of plucked hair for evaluation of immunologic remission in pemphigus vulgaris","volume":"65","author":"Daneshpazhooh","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R12-20241226","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cup.13494","article-title":"A comparative study of Michel's medium versus honey as a transport medium for skin specimens prior to direct immunofluorescence microscopy and antigen mapping","volume":"46","author":"Kumudhini","year":"2019","journal-title":"J Cutan Pathol"},{"key":"R13-20241226","article-title":"Use of multivariant enzyme-linked immunosorbent assay (ELISA) in diagnosis of autoimmune bullous disorders- perspective of a resource- limited setting","author":"De","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R14-20241226","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4103\/idoj.IDOJ_156_20","article-title":"Comparative analysis of BIOCHIP mosaic-based indirect immunofluorescence with direct immunofluorescence in diagnosis of autoimmune bullous diseases:A cross-sectional study","volume":"11","author":"Arunprasath","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"R15-20241226","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jaad.2020.01.049","article-title":"Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology","volume":"83","author":"van Beek","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R16-20241226","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R17-20241226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jid.2018.04.042","article-title":"Large international validation of ABSIS and PDAI pemphigus severity scores","volume":"139","author":"H\u00e9bert","year":"2019","journal-title":"J Invest Dermatol"},{"key":"R18-20241226","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/odi.14320","article-title":"ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris:Inter-rater reliability and testing times","volume":"29","author":"Shamabadi","year":"2023","journal-title":"Oral Dis"},{"key":"R19-20241226","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fmed.2020.00449","article-title":"Pemphigus oral lesions intensity score (POLIS):A novel scoring system for assessment of severity of oral lesions in pemphigus vulgaris","volume":"7","author":"Sindhuja","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R20-20241226","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.14405","article-title":"Calculation of cut-off values based on the autoimmune bullous skin disorder intensity score (ABSIS) and pemphigus disease area index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus","volume":"175","author":"Boulard","year":"2016","journal-title":"Br J Dermatol"},{"key":"R21-20241226","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"R22-20241226","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.1987.01660300105021","article-title":"Dapsone as initial treatment in superficial pemphigus. Report of nine cases","volume":"123","author":"Basset","year":"1987","journal-title":"Arch Dermatol"},{"key":"R23-20241226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R24-20241226","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fmed.2018.00315","article-title":"Pemphigus foliaceus-repeated treatment with rituximab 7 years after initial response:A case report","volume":"5","author":"Kraft","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R25-20241226","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2018.05.1252","article-title":"Rituximab treatment of pemphigus foliaceus:A retrospective study of 12 patients","volume":"85","author":"Palacios-\u00c1lvarez","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R26-20241226","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40257-014-0101-9","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus:A systematic review and meta-analysis","volume":"15","author":"Atzmony","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"R27-20241226","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1468-3083.2004.00980.x","article-title":"Topical tacrolimus (protopic) for the treatment of a localized pemphigus foliaceus","volume":"18","author":"Termeer","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R28-20241226","first-page":"443","article-title":"Recalcitrant lesions of pemphigus foliaceous at a surgical site:Successful treatment with tacrolimus 0.1% ointment","volume":"16","author":"Cassano","year":"2006","journal-title":"Eur J Dermatol"},{"key":"R29-20241226","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux3):A prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"R30-20241226","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/bjd.18482","article-title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect","volume":"182","author":"Chen","year":"2020","journal-title":"Br J Dermatol"},{"key":"R31-20241226","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2028564","article-title":"Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris","volume":"384","author":"Werth","year":"2021","journal-title":"N Engl J Med"},{"key":"R32-20241226","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","article-title":"Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus:A randomized, prospective study","volume":"26","author":"Ioannides","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R33-20241226","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"R34-20241226","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil:A multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R35-20241226","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","article-title":"Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris","volume":"27","author":"Chams-Davatchi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R36-20241226","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus:Results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"R37-20241226","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","article-title":"Therapy with rituximab for autoimmune pemphigus:Results from a single-center observational study on 42 cases with long-term follow-up","volume":"67","author":"Cianchini","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R38-20241226","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch Dermatol"},{"key":"R39-20241226","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R40-20241226","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2011.10732.x","article-title":"Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris","volume":"166","author":"Behzad","year":"2012","journal-title":"Br J Dermatol"},{"key":"R41-20241226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2133.2011.10585.x","article-title":"Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil:A pilot study of 23 patients","volume":"166","author":"Kasperkiewicz","year":"2012","journal-title":"Br J Dermatol"},{"key":"R42-20241226","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0378-6323.55390","article-title":"Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris","volume":"75","author":"Sethy","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R43-20241226","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.12073","article-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","volume":"38","author":"Sharma","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R44-20241226","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1038\/s41598-022-11387-2","article-title":"A randomised clinical trial to assess the adjuvant potential of methotrexate to corticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris","volume":"12","author":"Jain","year":"2022","journal-title":"Sci Rep"},{"key":"R45-20241226","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"R46-20241226","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/ced.15213","article-title":"Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus","volume":"47","author":"Singh","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R47-20241226","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bjd.12972","article-title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus:A randomized, comparative, observer-blinded study","volume":"170","author":"Kanwar","year":"2014","journal-title":"Br J Dermatol"},{"key":"R48-20241226","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2340\/00015555-2116","article-title":"Efficacy of rituximab for pemphigus:A systematic review and meta-analysis of different regimens","volume":"95","author":"Wang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R49-20241226","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/idoj.idoj_558_23","article-title":"Comparison of the clinical efficacy of rituximab infusion and dexamethasone-cyclophosphamide pulse therapy and their effect on serum Th1, Th2, and Th17 cytokines in pemphigus vulgaris\u2013A prospective, nonrandomized, comparative pilot study","volume":"15","author":"Khandpur","year":"2024","journal-title":"Indian Dermatol Online J"},{"key":"R50-20241226","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R51-20241226","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1684\/ejd.2023.4631","article-title":"Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse:Results of a prospective bicontinental cohort study","volume":"33","author":"De","year":"2023","journal-title":"Eur J Dermatol"},{"key":"R52-20241226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamadermatol.2020.0290","article-title":"Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy:A post hoc analysis of a randomized clinical trial","volume":"156","author":"Mignard","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R53-20241226","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamadermatol.2023.5679","article-title":"Sustained remission without corticosteroids among patients with pemphigus who had rituximab as first-line therapy:Follow-up of the ritux3 trial","volume":"160","author":"Tedbirt","year":"2024","journal-title":"JAMA Dermatol"},{"key":"R54-20241226","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jaad.2015.10.051","article-title":"Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission","volume":"74","author":"Daneshpazhooh","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R55-20241226","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/ijdvl.IJDVL_89_19","article-title":"Identification of clinical and immunological factors associated with clinical relapse of pemphigus vulgaris in remission","volume":"86","author":"Guliani","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R56-20241226","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-4362.1998.00317.x","article-title":"Epidemiologic observations on the natural course of pemphigus vulgaris","volume":"37","author":"Kyriakis","year":"1998","journal-title":"Int J Dermatol"},{"key":"R57-20241226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjd.18563","article-title":"Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen:Data from a national multicentre trial","volume":"183","author":"H\u00e9bert","year":"2020","journal-title":"Br J Dermatol"},{"key":"R58-20241226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijdvl.IJDVL_848_17","article-title":"Effectiveness and safety analysis of rituximab in 146 Indian pemphigus patients:A retrospective single-center review of up to 68 months follow-up","volume":"86","author":"De","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R59-20241226","doi-asserted-by":"crossref","first-page":"e15704","DOI":"10.1111\/dth.15704","article-title":"Long-term efficacy and safety analysis of single cycle of biosimilar rituximab in pemphigus:A retrospective study of 76 patients from India","volume":"35","author":"Shah","year":"2022","journal-title":"Dermatol Ther"},{"key":"R60-20241226","first-page":"adv00286","article-title":"Efficacy of repeated courses of rituximab as treatment for pemphigus vulgaris","volume":"100","author":"Baum","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"R61-20241226","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/ijd.16314","article-title":"Pediatric autoimmune blistering disorders \u2013A five-year demographic profile and therapy experience","volume":"61","author":"Mahajan","year":"2022","journal-title":"Int J Dermatol"},{"key":"R62-20241226","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1525-1470.2011.01514.x","article-title":"Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris","volume":"28","author":"Mabrouk","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R63-20241226","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.3390\/jcm11226858","article-title":"Childhood pemphigus vulgaris during COVID-19 outbreak successfully treated with prednisone and azathioprine:A case report and literature review","volume":"11","author":"Vezzoli","year":"2022","journal-title":"J Clin Med"},{"key":"R64-20241226","doi-asserted-by":"crossref","first-page":"1062.e1","DOI":"10.1016\/j.jpeds.2014.07.023","article-title":"Pemphigus foliaceus in an adolescent","volume":"165","author":"Adah","year":"2014","journal-title":"J Pediatr"},{"key":"R65-20241226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1525-1470.2012.01730.x","article-title":"Pediatric pemphigus vulgaris:Durable treatment responses achieved with prednisone and mycophenolate mofetil (MMF)","volume":"30","author":"Baratta","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R66-20241226","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/ped.14327","article-title":"Mycophenolate mofetil in the treatment of childhood pemphigus vulgaris","volume":"62","author":"Antonucci","year":"2020","journal-title":"Pediatr Int"},{"key":"R67-20241226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1525-1470.2001.018001051.x","article-title":"Complete recovery from juvenile pemphigus vulgaris","volume":"18","author":"Harangi","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"R68-20241226","first-page":"347","article-title":"Pemphigus vulgaris in childhood","volume":"60","author":"Koturoglu","year":"2008","journal-title":"A case report. Minerva Pediatr"},{"key":"R69-20241226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000287254","article-title":"Rituximab in childhood pemphigus vulgaris:A long-term follow-up case and review of the literature","volume":"221","author":"Fuertes","year":"2010","journal-title":"Dermatology"},{"key":"R70-20241226","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2014.05.071","article-title":"Successful use of rituximab in the treatment of childhood and juvenile pemphigus","volume":"71","author":"Vinay","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R71-20241226","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pde.13750","article-title":"Childhood pemphigus foliaceus presenting as a polycyclic eruption:Case report and review of the literature","volume":"36","author":"Evans","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R72-20241226","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1525-1470.2008.00808.x","article-title":"Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulin therapy","volume":"26","author":"Asarch","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R73-20241226","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1346-8138.2011.01354.x","article-title":"Case of juvenile pemphigus vulgaris which responded to iv immunoglobulin therapy","volume":"39","author":"Matsuda","year":"2012","journal-title":"J Dermato"},{"key":"R74-20241226","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy:Analysis of current data on the management and outcomes","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet Gynecol Surv"},{"key":"R75-20241226","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0378-6323.82404","article-title":"Pemphigus and pregnancy:A 23-year experience","volume":"77","author":"Daneshpazhooh","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R76-20241226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0035-1556743","article-title":"Update on the teratogenicity of maternal mycophenolate mofetil","volume":"4","author":"Coscia","year":"2015","journal-title":"J Pediatr Genetics"},{"key":"R77-20241226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update:Methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R78-20241226","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","volume":"2015","author":"Chi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R79-20241226","doi-asserted-by":"crossref","first-page":"e038","DOI":"10.1097\/JW9.0000000000000038","article-title":"Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy","volume":"8","author":"Dehghanimahmoudabadi","year":"2022","journal-title":"Int J Womens Dermatol"},{"key":"R80-20241226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R81-20241226","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jceh.2018.06.010","article-title":"INASL guidelines on management of hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosupressants, or corticosteroids","volume":"8","author":"Arora","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"R82-20241226","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R83-20241226","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy:ASCO provisional clinical opinion update","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"key":"R84-20241226","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"key":"R85-20241226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","article-title":"Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?","volume":"61","author":"Di Bisceglie","year":"2015","journal-title":"Hepatology"},{"key":"R86-20241226","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"R87-20241226","first-page":"454","article-title":"Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation","volume":"29","author":"Hori","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"R88-20241226","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.0954-6820.1983.tb03747.x","article-title":"The influence of uremia on pharmacokinetics and protein binding of prednisolone","volume":"213","author":"Bergrem","year":"1983","journal-title":"Acta Med Scand"},{"key":"R89-20241226","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1984.tb05022.x","article-title":"Influence of dialysis on prednisolone kinetics","volume":"215","author":"Bj\u00f6rck","year":"1984","journal-title":"Acta Med Scand"},{"key":"R90-20241226","article-title":"Dosage Adjustment for Cytotoxics in Renal Impairment","author":"Daniels","year":"2003","journal-title":"The North London Cancer Network"},{"key":"R91-20241226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"R92-20241226","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-197110000-00003","article-title":"The metabolism of azathioprine in renal failure","volume":"12","author":"Bach","year":"1971","journal-title":"Transplantation"},{"key":"R93-20241226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00403-022-02346-y","article-title":"Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors:A systematic review and meta-analysis","volume":"315","author":"Rokni","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R94-20241226","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"R95-20241226","doi-asserted-by":"crossref","first-page":"e14299","DOI":"10.1111\/dth.14299","article-title":"Adverse electrocardiographic effects of rituximab infusion in pemphigus patients","volume":"33","author":"Aidi","year":"2020","journal-title":"Dermatol Ther"},{"key":"R96-20241226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamadermatol.2022.5182","article-title":"Association of rituximab with risk of long-term cardiovascular and metabolic outcomes in patients with pemphigus","volume":"159","author":"Kridin","year":"2023","journal-title":"JAMA Dermatol"},{"key":"R97-20241226","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.12788\/cutis.0526","article-title":"Pemphigus vulgaris aggravated:Rifampicin found at the scene of the crime","volume":"109","author":"Hu","year":"2022","journal-title":"Cutis"},{"key":"R98-20241226","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5114\/ada.2018.72744","article-title":"Mycobacterium tuberculosis and pemphigus vulgaris","volume":"35","author":"Osipowicz","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"R99-20241226","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13555-019-00346-x","article-title":"A comparison of azathioprine and mycophenolate mofetil as adjuvant drugs in patients with pemphigus:A retrospective cohort study","volume":"10","author":"Sukanjanapong","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R100-20241226","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris:A long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R101-20241226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.38.1.51","article-title":"Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone","volume":"38","author":"Bovornkitti","year":"1960","journal-title":"Dis Chest"},{"key":"R102-20241226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-84-3-261","article-title":"The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population","volume":"84","author":"Schatz","year":"1976","journal-title":"Ann Intern Med"},{"key":"R103-20241226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7241\/ourd.20222.11","article-title":"Refractory pemphigus vulgaris with extrapulmonary tuberculosis:A challenging case management with rituximab","volume":"13","author":"Ramesh","year":"2022","journal-title":"Nasza Dermatol Online"},{"key":"R106-20241226","doi-asserted-by":"crossref","first-page":"825796","DOI":"10.3389\/fimmu.2022.825796","article-title":"A novel combined use of dupilumab for treatment of aggressive refractory pemphigus vulgaris complicated with pulmonary tuberculosis:A case report and the RNA-seq analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"R107-20241226","first-page":"41","article-title":"Risk of tuberculosis reactivation with rituximab therapy","volume":"11","author":"Alkadi","year":"2017","journal-title":"Int J Health Sci"},{"key":"R108-20241226","first-page":"97","article-title":"Pemphigus vulgaris in a human-immunodeficiency-virus-infected patient","volume":"197","author":"Capizzi","year":"1998","journal-title":"Dermatology"},{"key":"R110-20241226","first-page":"e1","article-title":"Pemphigus and diabetes mellitus:A systematic review and meta-analysis","volume":"60","author":"Phan","year":"2020","journal-title":"Int J Dermatol"},{"key":"R111-20241226","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/pde.15095","article-title":"Management of pediatric pemphigus vulgaris with rituximab:A case report and review of the literature","volume":"39","author":"Mistry","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"R112-20241226","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res"},{"key":"R113-20241226","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/jdv.16334","article-title":"Osteoporosis and bone health in autoimmune blistering skin disease\u2014An evidenced based review","volume":"34","author":"Kang","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R114-20241226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2340\/00015555-2611","article-title":"Mortality and cause of death in patients with pemphigus","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"R115-20241226","first-page":"312","article-title":"Serologic biomarkers in pemphigus monitoring:C-reactive protein, macrophage migration inhibitory factor, and prolactin levels versus autoantibody assays","volume":"22","author":"Mortazavi","year":"2023","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R116-20241226","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"R117-20241226","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R118-20241226","doi-asserted-by":"crossref","first-page":"e253507","DOI":"10.1136\/bcr-2022-253507","article-title":"Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis","volume":"16","author":"Akham","year":"2023","journal-title":"BMJ Case Rep"},{"key":"R119-20241226","first-page":"e15449","article-title":"Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris:Results from an open-label, prospective, pilot study","author":"De","year":"2022","journal-title":"Dermatol Ther"},{"key":"R120-20241226","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2230.2004.01499.x","article-title":"Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris","volume":"29","author":"Gach","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"R121-20241226","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5152\/eurjrheum.2016.16100","article-title":"Vaccination recommendations for adult patients with rheumatic diseases","volume":"3","author":"Tanr\u0131\u00f6ver","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"R122-20241226","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R124-20241226","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.2023.9844","article-title":"Prophylaxis against pneumocystis jirovecii pneumonia in adults","volume":"330","author":"Zhou","year":"2023","journal-title":"JAMA"},{"key":"R125-20241226","doi-asserted-by":"crossref","first-page":"e15257","DOI":"10.1111\/dth.15257","article-title":"Evaluating the risk-to-benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab:A retrospective study with 494 patients","volume":"35","author":"Faraji","year":"2022","journal-title":"Dermatol Ther"},{"key":"R126-20241226","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2017.01.059","article-title":"Venous thromboembolism in patients with pemphigus:A cohort study","volume":"77","author":"Leshem","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R127-20241226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2249.2009.03989.x","article-title":"Coagulation activation in autoimmune bullous diseases","volume":"158","author":"Marzano","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R128-20241226","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1468-3083.2010.03584.x","article-title":"Pemphigus, analysis of 155 patients","volume":"24","author":"Mimouni","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R129-20241226","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archinte.167.14.1476","article-title":"Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients:A meta-analysis of randomized controlled trials","volume":"167","author":"Wein","year":"2007","journal-title":"Arch Intern Med"},{"key":"R130-20241226","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1538-7836.2011.04182.x","article-title":"Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients","volume":"9","author":"Laporte","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R131-20241226","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism:Optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"key":"R133-20241226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25259\/IJDVL_1067_2024","article-title":"Construction and validation of an audio-visual tool to instruct caregivers of patients with pemphigus in photographing skin and oral cavity lesions during tele-consultation:A cross-sectional study","author":"Prarthana","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R134-20241226","first-page":"1338","article-title":"Successful treatment of pemphigus vulgaris with ofatumumab","volume":"17","author":"Rapp","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R135-20241226","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1172\/JCI138416","article-title":"Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1059_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:24Z","timestamp":1786649964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1059_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_1059_24","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"2024-10-20 2024-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}